tiprankstipranks
ANEST IWATA Corp. (JP:6381)
:6381
Japanese Market
Want to see JP:6381 full AI Analyst Report?

ANEST IWATA Corp. (6381) AI Stock Analysis

0 Followers

Top Page

JP:6381

ANEST IWATA Corp.

(6381)

Select Model
Select Model
Select Model
Outperform 83 (OpenAI - 5.2)
Rating:83Outperform
Price Target:
¥1,948.00
▲(19.22% Upside)
Action:Reiterated
Date:05/14/26
The score is driven primarily by strong financial quality (notably the very low leverage and solid profitability) and an attractive valuation (low P/E with a high dividend yield). Technicals are supportive with the stock above major moving averages, but slightly extended momentum and historically uneven cash conversion temper the overall rating.
Positive Factors
Conservative Balance Sheet
Exceptionally low leverage and steadily growing equity give durable financial flexibility. This enables funding of capex, R&D, dividends or M&A without reliance on costly debt, improving resilience in downturns and preserving long-term strategic optionality.
Negative Factors
Margin Volatility
Operating margins have swung across periods, reducing earnings predictability. Persistent margin volatility complicates capital allocation and strategic planning and may signal exposure to commodity/input cost swings, product-mix shifts or operating leverage limits.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative Balance Sheet
Exceptionally low leverage and steadily growing equity give durable financial flexibility. This enables funding of capex, R&D, dividends or M&A without reliance on costly debt, improving resilience in downturns and preserving long-term strategic optionality.
Read all positive factors

ANEST IWATA Corp. (6381) vs. iShares MSCI Japan ETF (EWJ)

ANEST IWATA Corp. Business Overview & Revenue Model

Company Description
ANEST IWATA Corporation engages in the air energy and coating businesses in Japan and internationally. The company offers air compressors and nitrogen gas generators for various applications, such as factories, food production, hospitals, electric...
How the Company Makes Money
ANEST IWATA primarily makes money by manufacturing and selling industrial equipment used in production and finishing processes. Key revenue streams include: (1) Coating/painting equipment sales—revenue from spray guns, coating/painting systems, an...

ANEST IWATA Corp. Financial Statement Overview

Summary
Strong overall fundamentals supported by steady revenue growth and solid profitability, plus an exceptionally conservative balance sheet with very low leverage and rising equity. The main offset is variability in operating margins and uneven cash conversion year-to-year.
Income Statement
78
Positive
Balance Sheet
90
Very Positive
Cash Flow
71
Positive
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue54.02B55.91B54.41B53.42B48.52B42.34B
Gross Profit25.43B26.14B26.08B24.48B21.34B18.23B
EBITDA8.31B8.05B8.39B8.43B7.91B6.54B
Net Income4.12B5.36B4.28B4.93B4.38B3.54B
Balance Sheet
Total Assets67.14B74.64B69.96B66.14B60.14B55.82B
Cash, Cash Equivalents and Short-Term Investments18.84B20.75B21.34B16.93B14.51B14.32B
Total Debt2.78B2.74B2.87B3.07B2.67B2.42B
Total Liabilities15.13B17.09B16.40B16.07B14.88B15.61B
Stockholders Equity45.95B50.75B46.85B44.16B40.03B35.62B
Cash Flow
Free Cash Flow0.004.94B7.08B4.95B2.48B3.02B
Operating Cash Flow0.008.14B9.75B6.77B4.33B3.89B
Investing Cash Flow0.00-4.33B-3.25B-1.26B-3.32B-1.08B
Financing Cash Flow0.00-3.86B-3.93B-3.58B-2.36B-2.10B

ANEST IWATA Corp. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1634.00
Price Trends
50DMA
1619.89
Positive
100DMA
1635.17
Positive
200DMA
1570.29
Positive
Market Momentum
MACD
8.02
Negative
RSI
55.24
Neutral
STOCH
36.51
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6381, the sentiment is Positive. The current price of 1634 is above the 20-day moving average (MA) of 1626.55, above the 50-day MA of 1619.89, and above the 200-day MA of 1570.29, indicating a bullish trend. The MACD of 8.02 indicates Negative momentum. The RSI at 55.24 is Neutral, neither overbought nor oversold. The STOCH value of 36.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6381.

ANEST IWATA Corp. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
83
Outperform
¥65.90B7.903.95%2.75%25.75%
80
Outperform
¥73.11B12.402.63%2.11%0.91%
77
Outperform
¥72.29B11.842.79%4.22%7.91%
74
Outperform
¥41.02B10.493.95%-4.76%20.37%
67
Neutral
¥195.67B12.848.17%2.04%4.34%98.54%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
62
Neutral
¥72.43B13.343.09%7.43%47.68%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6381
ANEST IWATA Corp.
1,656.00
324.80
24.40%
JP:6376
Nikkiso Co., Ltd.
3,205.00
2,031.04
173.01%
JP:6237
Iwaki Co. Ltd.
3,300.00
814.30
32.76%
JP:6333
Teikoku Electric Manufacturing Co., Ltd.
2,829.00
-114.87
-3.90%
JP:6363
Torishima Pump Mfg.Co., Ltd.
2,813.00
885.26
45.92%
JP:6517
Denyo Co., Ltd.
3,680.00
1,076.32
41.34%

ANEST IWATA Corp. Corporate Events

ANEST IWATA Sets Long-Term Strategy to Realize Vision 2035
May 12, 2026
ANEST IWATA Corporation has unveiled a long-term growth strategy as a master plan to achieve its Vision 2035, signaling a structured roadmap for its future development. The plan outlines how the group intends to steer its operations and investment...
ANEST IWATA Launches Share Buyback to Boost Capital Efficiency
May 12, 2026
ANEST IWATA Corporation has approved a new share repurchase program as part of its broader capital policy and commitment to enhancing shareholder returns. The company aims to use flexible buybacks while preserving a solid financial base to support...
ANEST IWATA to Expand Business Scope with Automotive-Related Services
May 12, 2026
ANEST IWATA Corporation plans to amend its Articles of Incorporation to broaden its stated business purposes, reflecting an expansion and diversification of its business domains across the group. The proposal, approved by the board, will be submit...
ANEST IWATA Doubles Annual Dividend and Adopts DOE-Based Payout Policy
May 12, 2026
ANEST IWATA Corporation’s board has approved a year-end dividend of JPY 46.00 per share for the fiscal year ended March 31, 2026, with a record date of March 31 and an effective payment date of June 29, subject to shareholder approval. This ...
ANEST IWATA lifts sales and net profit, forecasts margin squeeze amid 100th anniversary investments
May 12, 2026
ANEST IWATA reported FY2025 net sales of 55,909 million yen, up 2.8% year on year, with growth driven by strong air compressor demand from European OEMs and higher sales of coating equipment and systems in China, Japan and India. Despite revenue g...
ANEST IWATA Lifts Earnings and Dividends but Flags Profit Dip Ahead
May 12, 2026
ANEST IWATA reported fiscal 2025 consolidated net sales of ¥55.9 billion, up 2.8% year on year, with operating profit slipping 5.8% to ¥5.56 billion but ordinary profit rising 8.1% and profit attributable to owners of parent jumping 25.2...
ANEST IWATA Revamps Board Lineup With New Outside Director, Maintains Leadership Stability
Mar 18, 2026
ANEST IWATA Corporation has announced a slate of director candidates, primarily consisting of reappointments of its existing leadership team, including President and CEO Eisuke Miyoshi, for approval at its 80th Annual General Meeting of Shareholde...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 14, 2026